The Hyderabad-based Helix Genomics Pvt. Ltd (HGPL), a Bio-computational research-based company has announced setting up its Branch Office Operations at London. This will facilitate in expanding business and cater to the growing European Biotech and Pharmaceutical markets.

Elaborating on the HGPL plans, Mohan RK Nimmagadda, CEO and director stated that HGPL is ambitious and will be improving its target base to eventually emerge as the global Bio-Computational CRO major and provide comprehensive and customized solutions to the industry.

As part of this initiative, Dr. Rajani Kanth Vangala has joined formally as director & chief scientific officer for Helix and will look after its London operations and will be involved in product development, contract research and consulting.

Adding further, Mohan said, HGPL would strengthen its marketing efforts by entering into multiple marketing alliances and collaborations across Europe. Additionally, HGPL will focus on Software Licensing / Marketing and Contract Research activity and provide custom solutions in Europe.

"HGPL technologies will be key drivers to faster and effective R & D initiatives and we offer custom designed solutions, products and services to the global Biotech / Pharmaceutical industry and to academia," he added.